The first end-to-end remotely guided transcatheter aortic valve implantation...
Abbott has received Breakthrough Device designation from the US Food and Dru...
Royal Philips has announced the official start of the DEFINE GPS study, with...
After speaking with experts, reviewing current evidence, surveying people living...
Data captured in the National Cardiovascular Data Registry (NCDR) is similar...
An investigation into the impact of postoperative complications on long-term qua...

Cindy Grines

Cindy Grines is an interventional cardiologist and chief scientific officer of N...
In patients with acute coronary syndrome treated with percutaneous coronary ...
The number of people dying from cardiovascular disease (CVD) in Asia is increasi...
CorWave has announced that it has successfully completed the first 90-day precli...
Circulation the flagship journal of the American Heart Association (AHA) has pub...
Shockwave Medical has announced today that the Centers for Medicare & Medica...
A study looking at the timing of coronary artery bypass grafting (CABG) after th...
Pivotal trials of transcatheter aortic valve implantation (TAVI) in low-risk...
Neurescue has announced that the US Food and Drug Administration (FDA) has grant...
A new physiological measurement of heart function could improve survival for...
Early experience with the Evoque (Edwards Lifesciences) tricuspid valve replacem...
GE Healthcare is collaborating with the American College of Cardiology (ACC) thr...
Medtronic is stopping the distribution and sale of the Medtronic HVAD system...
This advertorial is sponsored by Sinomed As newer-generation drug-eluting...
Rupert Bauersachs (Darmstadt, Germany) talks to Cardiovascular News about th...
 John Forrest (New Haven, USA) sits down with Cardiovascular News to talk ab...
Our top 10 stories of May 2021, including highlights from both EuroPCR 2021 (18–...
There does not appear to be a relationship between operator and patient gender a...
Siemens Healthineers has announced that it has received CE Mark for the AcuNav V...
LivaNova has successfully completed the initial closing of the divestiture o...
Women who experience acute aortic dissection are older, have more advanced d...
Abiomed has acquired preCARDIA, developer of a proprietary catheter and controll...
Sinomed has announced results from the HT Supreme healing-targeted drug-elut...
There is an increasing understanding of the need for tailored strategies when tr...
A call for greater investment in surgical facilities in the UK in the wake of th...
Interventional cardiologists from across the globe are joining forces for a ...
This advertorial is sponsored by Shockwave Medical. Severe coronary artery ca...
The European Union (EU) Medical Devices Regulation (MDR) takes effect from today...
Foldax has announced the successful first-in-human use of its biopolymer Tria he...
Procyrion has announced the treatment of the first patients in the pilot trial t...
 Ajay Kirtane (New York, USA) talks to Cardiovascular News about the RADIANC...
Investigation of the use of an ultra-thin strut biopolymer sirolimus-eluting...
This advertorial is sponsored by Boston Scientific In recent years, trans...
OrbusNeich and P&F Products & Features, under the joint partnership Orbu...
Results of an observational study using optical coherence tomography (OCT) t...
One-year results of the FUTURE-II study—a randomised trial comparing a thin-...
A meta-analysis of randomised trials comparing a strategy of revascularisation p...
Clopidogrel monotherapy produced better outcomes than aspirin for the long-t...
HeartFlow has announced new data which indicate that the information provide...
Rivaroxaban (Xarelto, Bayer/Janssen), in addition to low-dose aspirin, shoul...
Complete two-year follow-up data from the Evolut Low Risk trial, presented d...
Long-term follow-up data from the BIOSOLVE-IV registry, presented at the Eur...
This advertorial is sponsored by PIE Medical Findings of the multicentre ...
Data presented at hotline and late-breaking trial sessions at the EuroPCR 20...
Royal Philips has announced the European availability of new innovations in its ...
ZOLL Medical Corporation has announced that the US Food and Drug Administrat...
Abbott has announced it has received CE mark for its latest-generation transcath...
Among patients with suspected acute coronary syndrome (ACS), the use of a hi...
The proportion of cardiologists reporting burnout has nearly doubled during ...
ST-elevation Myocardial Infarction (STEMI) patients with multi-vessel diseas...
Switching from ticagrelor to clopidogrel dual antiplatelet therapy (DAPT) af...
Transcatheter left atrial appendage occlusion (LAAO) with a Watchman (Boston...
Apixaban was not superior to standard of care following transcatheter aortic...
Patients with an elevated risk of stroke due to arrhythmia or atrial fibrillatio...
CeloNova BioSciences that its COBRA PzF nanocoated coronary stent (NCS) achi...
Royal Philips has announced the integration of its Interventional Hemodynamic sy...
This advertorial is sponsored by Pi-Cardia As more transcatheter aortic valve...
This advertorial is sponsored by Osprey Medical There is a growing recognitio...
Discrimination and harassment are a common experience among those working in car...
In this issue: Hostile environment: How cardiologists feel about discrimina...
In this issue: Hostile environment: How cardiologists feel about disc...
Research presented at the American Association for Thoracic Surgery 101st Annual...
Fewer than half (48%) of patients undergoing percutaneous coronary intervent...
A significant proportion of cardiology trainees are uncomfortable with using...
Boston Scientific has announced it has initiated the AGENT IDE trial for the Age...
Mild COVID-19 infection is unlikely to cause lasting damage to the structure or ...
Abbott has announced a new trial focused on improving the treatment for people s...
Our top 10 stories of April 2021, including: highlights from the Society for Car...
ST-elevation myocardial infarction (STEMI) patients received percutaneous corona...
Timothy D Henry (The Christ Hospital Medical, Cincinnati, USA) has assumed t...
Patients suffering from severe mitral regurgitation should be carefully screened...
Medtronic has announced that it has received the CE mark for the Evolut PRO+...
Patients studied in the ISCHEMIA trial, the largest trial to date to compare...
Robotic-assisted percutaneous coronary intervention (PCI) using the second-g...
Analysis of the prospective Fuwai PCI Registry using selection criteria from the...
The Society for Cardiovascular Angiography and Interventions (SCAI) has released...
Two research papers presented at the Society for Cardiovascular Angiography ...
Medtronic has announced results from an interim analysis of the first 171 pa...
Patients hospitalised with COVID-19 may be at risk of developing heart failu...
Phoenix Cardiac Devices has announced that it has received CE mark for its Basal...
CytoSorbents has announced that the US Food and Drug Administration (FDA) has gr...
Initial findings from the North American Cardiovascular COVID-19 Myocardial ...
Abiomed has announced that the first patient has been enrolled in PROTECT IV...
Researchers from King's College London (London, UK) have created 3D replicas of ...
A retrospective observational study of patients undergoing cardiac surgery in th...
The work of the Cardiothoracic Surgical Trials Network (CTSN) in mobilising reso...
Acutus Medical has announced US Food and Drug Administration (FDA) clearance of ...
The first procedure has been completed in SMART (Small Annuli Randomized to ...
Abbott has received CE mark for its next-generation TriClip transcatheter tricus...
Our top 10 stories of March 2021, including: highlights from CRT 2021; convergin...
More patients, particularly those with medical risk factors or from underser...
With recent data pointing to a shift towards more transcatheter aortic valve imp...
Abbott has announced that its Xience stent has received CE mark in Europe fo...
Dipti Itchhaporia has today begun her term as president of the American Coll...
ClearFlow has announced clinical trial results published in the Journal of Cardi...
More than a third of female cardiologists polled in a UK survey on discriminatio...
Patients aged over 65 years were more likely than their younger counterparts to ...
Matheen Khuddus (director of Cardiovascular Research, The Cardiac & Vascular...
B Braun Interventional Systems has announced a collaboration with Infraredx to a...
Alvimedica has announced CE mark approval of Fluydo NC, its PTCA non-compliant b...
Medtronic has received US Food and Drug Administration (FDA) approval for its Ha...
Social media has become an important platform for promoting research within the ...
Endotronix has announced the 100th global implant of the Cordella pulmonary ...
Men with stable coronary artery disease who receive Viagra due to impotence ...
Shockwave Medical has announced that the company has signed an agreement to form...
Bristol Myers Squibb has announced that the US Food and Drug Administration (FDA...
 Speaking to Cardiovascular News, Georg Nickenig (Bonn, Germany) details the...

Stephan Achenbach

Stephan Achenbach is professor of medicine at the University of Erlangen, Erlang...
Three-year results from the COMPARE-ABSORB trial, presented during a late-br...
Three-year clinical outcomes from the Recre8 trial, a multicentre study comparin...
Lab-created heart valves implanted in young lambs were capable of growth wit...
Imbio has received US Food and Drug Administration (FDA) 510(k) clearance for it...
Cardiovascular Systems has announced that the first patients in the USA have bee...
CytoSorbents has announced the filing of an investigational device exemption (ID...
Elixir Medical has today announced commencement of the INFINITY-SWEDEHEART rando...
Ahmed Bendary (Benha University, Benha, Egypt) details the CardioRisk projec...
Two-year follow-up data the BIOSTEMI trial, presented during a late-breaking...
Thomas Pilgrim (Bern, Switerland) details two-year results from the BIOSTEMI r...
Clinical outcomes up to one year after transcatheter aortic valve implantati...
Five-year follow-up results from the Gore REDUCE study, assessing the Gore C...
The American College of Cardiology (ACC) has announced a number of the late-brea...
Registry data charting the use of direct oral anticoagulants (DOACs) in pati...
Data from an international registry of patients undergoing a procedure known...
Our top 10 stories of February 2021, including: the relationship between TAVI vo...
Following consultation with its notified body, MEDCERT GmbH, Abiomed is introduc...
ControlRad has announced US Food and Drug Administration (FDA) 510(k) cleara...
Favourable rates of ischaemic outcomes were observed among selected high ble...
A global collaboration between international heart failure bodies seeks to stand...
MedAlliance has been awarded breakthrough status for Selution SLR, its sustained...
Innovative Cardiovascular Solutions (ICS) has announced the success of its f...
Vascular Grafts Solutions has announced receipt of marketing clearance from the ...
Two-year outcomes of the PARTNER 3 clinical trial, in which low surgical ris...
An analysis of antiplatelet therapies used during percutaneous coronary inte...
A secondary analysis of the COAPT trial, which sought to account for differe...
Elucid, a developer of AI software to enable cardiovascular disease detection, h...
Inovise Medical has announced that the US Food and Drug Administration (FDA)...
Occlutech has announced the completion of patient enrolment in its pilot study t...
A sub-analysis of the DISRUPT CAD III clinical trial, investigating use of S...
After Shockwave Medical announced that its intravascular lithotripsy (IVL) techn...
Terumo Corporation has signed a definitive agreement to acquire all assets of He...
The American College of Cardiology (ACC) has announced that its 70th annual scie...
Urgent action is needed to address the growing burden of heart failure and t...
A sub-analysis of the Recre8 trial, assessing patients at high bleeding risk...
Caption Health has announced the publication of a study in JAMA Cardiology a...
OpSens has received CE mark approval for the OptoWire III, the latest generation...
Around 50% of patients who have been hospitalised with severe COVID-19 and h...
With the COVID-19 pandemic creating new barriers to the accessibility of hea...
Teleflex has announced the completion of patient enrolment in a clinical study e...
Shockwave Medical has announced that its intravascular lithotripsy (IVL) technol...
Dropping aspirin shortly after percutaneous coronary intervention (PCI) is a...
A study detailing early experience of the Pascal transcatheter valve system ...
Off-pump coronary artery bypass grafting (OPCABG) is a safe and effective option...
The number of patients with heart failure worldwide nearly doubled from 33.5 mil...
Robotic-assisted treatment is on the cusp of achieving its full potential, says ...
Updated recommendations on the optimal antithrombotic treatment of patients with...
The authors of a systematic review and meta-analysis, looking at the effect ...
MedAlliance has announced enrolment of the first patient in SUCCESS PTA, its lar...
iVascular has announced that its Angiolite drug-eluting stent (DES) is available...
Royal Philips has announced that it has completed the acquisition of BioTelemetr...
Puzzle Medical has announced that the US Food and Drug Administration (FDA) has ...
Cardiovascular Systems has announced that the first patient in Europe has be...
COVID-19 patients who suffer a cardiac arrest either in or out of hospital are f...
Drug-eluting stent implantation guided by intravascular ultrasound (IVUS) is ass...
A study published in the Journal of Cardiac Surgery, detailing 18 out of a group...
Cardiovascular Systems (CSI) has partnered with Chansu Vascular Technologies...
Minimally invasive aortic valve replacement (miAVR) in select patients with ...
Forge Medical has announced the publication of results of an investigator-initia...
The risk of burnout among cardiothoracic surgeons has been heightened by the...
Cardiothoracic surgeon Sean C Grondin from the University of Calgary (Calgary, C...
Five-year data from the COMMENCE clinical trial, presented at the 57th annua...
Women are significantly less likely than men to undergo coronary artery bypass g...
The COVID-19 pandemic has caused a substantial decline in overall heart surg...
A study of 356 patients treated with Impella 5.5 with SmartAssist (Abiomed) at 1...
An analysis of data from the ADAPT-DES registry, published in JACC: Cardiovascul...
Ancora Heart has announced enrolment of the first patient in the CORCINCH-HF...
PhaseBio Pharmaceuticals has expanded its pivotal phase 3 REVERSE-IT trial for b...
In this issue: Long-term registry data show TAVI has overtaken surgical aor...
In this issue: Long-term registry data show TAVI has overtaken surgical aor...
SIS Medical has announced the publication of the ISAR-CALC—ComparIson of Strateg...
Current scoring systems used to assess the risk of mortality in minimally in...
HeartFlow has announced that National Health Service England (NHSE) and NHS ...
Foldax has today announced publication of a research paper in Advanced NanoB...
Alleviant Medical has announced that the US Food and Drug Administration (FDA) h...
Aktiia has announced that its automated blood pressure monitoring system has...
A patient’s risk of coronary heart disease may be more accurately predicted ...
Analysis of data from English hospitals suggests that there was a sharp decline ...
Tributes have been paid to David Foley, professor of Interventional Cardiology a...
Cardiovascular Systems has received the CE mark for its Diamondback 360 coro...
Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, ...
Abbott has announced that the US Centers for Medicare & Medicaid Service...
Occlutech has announced that the US Food and Drug Administration (FDA) has grant...
Results from the EXTRACT-PE trial, which found that Penumbra’s Indigo aspira...
The British Heart Foundation (BHF) has warned of the potentially dire consequenc...
iVascular has announced that its Angiolite drug-eluting stent (DES) offers a 6mm...
Complete revascularisation is rarely achieved in patients with multivessel c...
Robocath has announced the successful completion of the first remote robotic...
The Foundry today announced the completion of the first-in-human procedure with ...
Inari Medical has announced US Food and Drug Administration (FDA) 510(k) clearan...
Medtronic Canada has received a new expanded indication from Health Canada f...
The American College of Cardiology (ACC) is partnering with BioIntelliSense, a c...
CathWorks reported the completion of a US$30 million Series D financing roun...
Specialists in congenital and adult cardiac and thoracic surgery have called...
The Cardiovascular Research Foundation (CRF) has announced today David J Coh...
Patients with acute heart failure nearly double their risk of dying if they ...
The US Food and Drug Administration (FDA) has cleared the use of EchoGo Pro ...
CorWave has rasied €35 million to fund the next stages of its development. The c...
BioVentrix has announced that heart failure specialist Jerry Estep (Clevelan...
VDYNE has announced today that it has secured a US$21 million Series C financing...
This advertorial is sponsored by Boston Scientific Results of the SCOPE I...
Jian’an Wang (Heart Center, Zhejiang University, Hangzhou, China) has been named...
Edwards Lifesciences has announced that the first patient has been treated i...
Michael Poon (Lenox Hill Hospital-Northwell Health, New York, USA) discusses the...
Edwards Lifesciences has announced that Health Canada has approved the expan...
Abbott has announced that the US Food and Drug Administration (FDA) has appr...
A subgroup analysis of the ISAR REACT-5—Intracoronary Stenting and Antithromboti...
New joint clinical practice guidelines on the treatment of patients with valvula...
Concept Medical has been granted "Breakthrough Device Designation" from the Cent...
Writing for Cardiovascular News, Harold Dauerman, Rony Lahoud and Newton Phu...
Foldax has announced that the US Food and Drug Administration (FDA) has granted ...
Paying patients are 20% less likely than NHS patients to die or develop majo...
Abiomed has announced that its Impella ECP heart pump has completed the first st...
Genetesis has announced that its flagship product, CardioFlux, has been granted ...
The American College of Cardiology (ACC) will collaborate with Amgen and Ver...
Corindus has announced today global launch of a new set of automated robotic...
Acutus Medical has announced CE mark approval and the European launch of its int...
Global leaders in the field of cardiothoracic surgery will debate the impact of ...
Abbott has announced the global release of its first virtual reality-based train...
Acarix has announces the enrolment of the final patient in the Dan-NICAD II ...
The first international registry of patients undergoing transcatheter mitral int...
Gilbert Tang (New York, USA) talks to Cardiovascular News about the key find...
Pre-existing coronary arterial disease (CAD) was associated with higher in‐hospi...
LivaNova has entered into an agreement with investment firm Gyrus Captial wh...
Cathy Gates has been named as the new CEO of the American College of Cardiol...
Reduced effectiveness of treatment and increased running costs are likely to hav...
Tim Henry (Cincinnati, USA) talks to Cardiovascular News about the initial f...
Please NOTE: This video is ONLY available to watch in selected countries and geo...
Baylis Medical has announced the publication of data demonstrating procedura...
A study published in the Journal of the American College of Cardiology (JACC) ha...
Women face a 20% increased risk of developing heart failure or dying within five...
Vectorious Medical Technologies has announced that the US Food and Drug Administ...
Philips has announced the next generation of its advanced visualisation workspac...
Gore has announced encouraging clinical results from its early feasibility study...
 Jörg Hausleiter (Munich, Germany) talks to Cardiovascular News about the o...
Long-term data on the outcomes of surgery after failed transcatheter edge-to...
Data from the EXPAND G4 study, evaluating the performance of the latest gene...
Eight-year findings from the NOTION I trial—the first all-comers trial to ra...
Emerging data supports transcatheter techniques to treat primary mitral regu...
Details of an early feasibility study of transcatheter mitral edge-to-edge r...
Two-year outcomes from the MITRAL trial, presented at PCR Valves e-course (2...
One-year findings from the EXPAND registry, evaluating real-world use of new...
The first randomised trial comparing a course of pre-procedure percutaneous ...
Discussion during the first day of the PCR Valves e-course (22–24 November, ...
University of Leicester and University Hospitals of Leicester NHS Trust (UHL), L...
A study published in ACS Biomaterials Science & Engineering details the deve...
Corvia has announced completion of randomisation in its REDUCE LAP-HF II glo...
Boston Scientific has announced a global recall of all unused inventory of i...
Sinomed has announced the presentation of data from its inter-continental PI...
The volume of transcatheter aortic valve implantation (TAVI) procedures in t...
Atrial fibrillation (AF) was detected up to 10 times more frequently in high...
Among patients who stopped taking statins due to side effects, researchers f...
A one-month treatment of dual anti-platelet therapy (DAPT) is safe and as ef...
The use of ticagrelor was not superior to clopidogrel in the reduction of th...
The primary results from the RIVER Trial—Rivaroxaban for Valvular Heart dise...
A pooled analysis of interventional studies assessing the feasibility, effic...
Append Medical, developer of the Appligator implant-free left atrial appenda...

Michael Reardon

A pioneer in the field of transcatheter aortic valve implantation (TAVI), Michae...
Heart valve procedures performed by cardiothoracic surgeons with 10 years of exp...
Structural racism is a major cause of poor health and premature death from heart...
Results of the Onyx One Clear study, evaluating the safety and effectiveness...
Abiomed has announced that the first 1,000 patients have been treated with the I...
A significant decline in percutaneous coronary intervention (PCI) procedures...
Payments from device manufacturers to physicians are likely to have a bearing on...
AstraZeneca’s Forxiga (dapagliflozin)—known as Farxiga—has been approved in the ...
The use of ticagrelor in patients with acute coronary syndrome (ACS) undergoing ...
MyoKardia has announced three awardees of the 2020 MyoSeeds research grant progr...
Kevin Croce, director, Chronic Total Occlusion and Complex Percutaneous Coro...
COVID-19 patients with a history of heart failure were associated with a longer ...
Late-breaking science in interventional cardiology is alive and well despite the...
Abiomed has announced the treatment of the first two patients using the Impella ...
Mounting evidence over the safety and efficacy of shorter-term dual antiplat...
Foldax has announced that the US Food and Drug Administration (FDA) has granted ...
The European Society of Cardiology (ESC) has announced that its full portfolio o...
BioCardia has announced the publication of data from the initial open-label roll...
A study published in the Journal of the American College of Cardiology (JACC) ha...
NOTE: This video is ONLY available to watch in selected countries and geographie...
The US Food and Drug Administration (FDA) has granted Abiomed a 510(k) clear...
Tricuspid annular dilatation (TAD) is an independent predictor of all-cause mort...
The American College of Cardiology (ACC) has published an expert consensus decis...
A research programme into understanding the underlying causes of unexplained car...
A meta-analysis of 23 randomised clinical trials comparing percutaneous coro...
Rhian E Davies (University of Washington Medical Center, Seattle, USA) discu...
The Journal of the American College of Cardiology (JACC) has issued a three-part...
Results of the OPTIMIZE IDE study, assessing the Svelte drug-eluting stent (DES)...
Biosensors has announced the award of a CE mark for BioFreedom Ultra drug-coated...
CeloNova BioSciences has announced interim results from the randomised Trial...
Results of the HOST-REDUCE-POLYTECH-ACS, presented at TCT Connect 2020 (14–1...
One-year follow-up results of the randomised SOLVE-TAVI trial showed similar rat...
One-year clinical outcomes from the global EXPAND study, reporting on the use of...
In this issue: POPular TAVI prompts call for aspirin-only antiplatelet stra...
Shockwave Medical has announced that the coronary Investigational Device Exempti...
In this issue: POPular TAVI prompts call for aspirin-only antiplatelet stra...
Royal Philips has announced one-year results of the DEFINE PCI study, presented ...
A shorter course of dual antiplatelet therapy (DAPT) after percutaneous coro...
Interventional closure of an iatrogenic atrial septal defect (iASD) driven by tr...
The REFLECT II randomised clinical trial evaluating the safety and efficacy of a...
Findings of the SCOPE II clinical trial, which were presented during a late ...
An interim analysis of the Restore EF Study, presented at TCT Connect 2020 (...
One in five high-risk patients undergoing major non-cardiac surgery will develop...
Cardiovascular Systems has announced the presentation of results from a larg...
Initial findings from the North American COVID-19 ST-Segment Elevation Myoca...
Medtronic has today announced a partnership with The Foundry—a medical device co...
A pilot randomised trial of percutaneous coronary intervention (PCI) of non-flow...
Medtronic has today announced plans to launch a randomised, head-to-head stu...
NuVera Medical has announced positive results from its first-in-human feasib...
LivaNova has announced new data from the Perceval Sutureless Implant Versus Stan...
The president of the European Association For Cardiothoracic Surgeons (EACTS...
“We now live in a world of wires,” commented Tom C Nguyen (chief of cardiac ...
Ahead of the first virtual edition of the Transcatheter Cardiovascular Thera...
Butterfly Network and the American College of Cardiology (ACC) have announced a ...
This article, part of an educational supplement sponsored by Siemens Healthine...
Patients with postoperative atrial fibrillation (AF) after coronary artery b...
AngelMed has announced the first implant of the next-generation AngelMed Guardia...
The European Society of Cardiology (ESC) and the European Association for Ca...
Javier Escaned (Hospital Universitario Clínico San Carlos, Madrid, Spain) discus...
An analysis of the rates and clinical implications of alternative definitions of...
Medtronic has announced that it has received US Food and Drug Administration...
Research has identified 2,085 excess deaths in England and Wales linked to cardi...
Cardiac Dimensions has closed a US$17.5 million series C financing round whi...
Boston Scientific has today announced it has initiated a controlled launch o...
InnovHeart has announced the successful first-in-human implantation of its propr...
Transcatheter aortic valve implantation (TAVI) device selection should be gu...
Over the last decade, the cath lab has transformed. Interventional cardiologists...
V-Wave has closed a Series C financing extension of up to US$98 million, assurin...
Medtronic has received Breakthrough Device Designation status from the US Food a...
After surviving a heart attack, the proportion of patients who experience a ...
Abbott has today announced it has received CE mark approval for its fourth-gener...
A study of US Medicare patients undergoing percutaneous coronary interventio...
The Cardiovascular Research Foundation (CRF) has announced that over 30 late-bre...

J Dawn Abbott

J Dawn Abbott is the director of interventional cardiology and an associate prof...
Aspirin-free prasugrel monotherapy following successful everolimus-eluting stent...
VitalConnect has announced the commencement of the TELESTAR-TAVR clinical st...
Healthcare professionals should become more familiar with medications that c...
Cardiac magnetic resonance imaging (MRI) is effective in identifying inflamm...
Survey results published to mark Heart Valve Disease Awareness Week show that ol...
Multiple studies have shown that fractional flow reserve (FFR) is a valuable mod...
Results of the TIDES-ACS randomised controlled trial, confirming the superio...
Medtronic has announced  US Food and Drug Administration (FDA) approval of an ea...
Researchers from the University of Minnesota, with support from Medtronic, have ...
Cardiac Dimensions has announced that Australia’s Therapeutic Goods Administrati...
Fujifilm Sonosite has received 510(k) clearance from the US Food & Drug Admi...
Japan and the USA have seen an increase in percutaneous coronary intervention (P...
Concept Medical has announced the enrolment of the first patient in the TRANSFOR...
CryoLife has announced the acquisition of Ascyrus Medical, developer of the Ascy...
The American College of Cardiology (ACC) has announced that its 70th Annual Scie...
BioVentrix has announced the resumption of cases in the pivotal ALIVE Trial stud...
An invasive approach involving either percutaneous coronary intervention (PC...
According to findings of the POPular CABG trial, the addition of ticagrelor ...
Royal Philips has announced the next-generation of its Azurion image-guided ...
Miracor Medical has announced the closing of a €24 million series-E round of...
Atrial fibrillation (AF) is associated with long-term mortality in patients ...
The POPular TAVI trial has challenged current recommendations on antiplatele...
Mavacamten (MyoKardia) improves heart function and symptoms in patients with...
Transcatheter mitral valve replacement (TMVR) with the Tendyne device (Abbott) r...
The European Society of Cardiology (ESC) has issued new guidelines, published on...
Empagliflozin reduces the risk of cardiovascular death or hospitalisation for he...
Medtronic has announced that the US Food and Drug Administration (FDA) has a...
Meta analysis puts spotlight on optimal DAPT duration Cardiologists warn ...
Meta analysis puts spotlight on optimal DAPT duration Cardiologists warn ...
In this educational supplement, sponsored by Siemens Healthineers, Cardiovas...
The inaugural CX Aortic Vienna meeting will be livestreamed 8–11 September 2020 ...
Philips announced today the latest addition to its portfolio of dedicated cardio...
Guidelines for reducing the risk of stroke in patients undergoing heart surg...
The Heart Rhythm Society has announced the publication of the inaugural issue of...
The risk of in-hospital death and in-hospital heart failure increased for ST-ele...
A study comparing recommendations from a heart team versus those of an inter...
  Representation of women leading heart failure research remains lim...
Transcatheter tricuspid valve replacement in the setting of trans-tricuspid ...
Royal Philips has announced the introduction of OmniWire, a solid core pressure ...
Ahead of the 2020 European Society of Cardiology (ESC) Congress, taking plac...
COVID-19 patients with cardiovascular comorbidities or risk factors are more lik...
Translumina has announced the publication of 10-year follow-up data on its d...
With whole sections of society migrating online during the COVID-19 pandemic...
Mental stress and anger may have clinical implications for patients with heart f...
Biosensors announced today the enrolment of the first patient in REFORM—a prospe...
A US survey released by patient advocacy group Heart-Valve-Surgery.com, with sup...
InnovHeart—developer of novel transcatheter mitral valve replacement (TMVR) syst...
The Journal of the American Heart Association (JAHA) has retracted a paper publi...
Thirty-day clinical outcomes from the FORWARD PRO international study of the...
CardioMech, developer of a transfemoral, transseptally delivered mitral valve re...
A meta-analysis of 24 randomised controlled trials assessing dual antiplatel...
Eko has announced a collaboration with AstraZeneca to accelerate the development...
The US Food and Drug Administration (FDA) has issued an emergency use author...
In this educational supplement, sponsored by Boston Scientific, Cardiovascular N...
As interventional cardiology continues to grow with higher risk patients and...
A German study of recently-recovered COVID-19 patients examined using magnetic r...
A three-year, investigator-led, prospective study of Japanese patients who r...
One-year outcomes of mitral valve-in-valve replacement using the Sapien 3 (E...
Keystone Heart has announced completion of the first worldwide commercial ca...
Use of non-steroidal anti-inflammatory drugs (NSAIDs) to treat first-time heart ...
The American College of Cardiology (ACC) is expanding its JACC family of peer-re...
The US Food and Drug Administration (FDA) has approved one-way digital data ...
Aortic valve replacement, using either transcatheter aortic valve implantati...
Caption Health, a developer of medical artificial intelligence (AI) technolo...
MyoKardia has announced that the US Food and Drug Administration (FDA) has grant...
Digital health and artificial intelligence (AI) company Eko has been awarded a U...
Genetic testing and counselling for inherited cardiovascular diseases may he...
Findings of a US investigation of clinician race and gender bias in decision...
Scitech has announced that the Inspiron coronary sirolimus eluting stent has rec...
Boston Scientific has received US Food and Drug Administration (FDA) approva...
LifeSignals Group has announced that it has received US Food and Drug Administra...
Azeem Latib (New York, USA) spoke to Cardiovascular News about a sub-analysi...
  Philipp Lurz (Leipzig, Germany) speaks to Cardiovascular News abou...
LivaNova has announced that the advanced Perceval Plus sutureless surgical aorti...
Women taking beta blockers for hypertension with no prior history of cardiovascu...
A rise in the number of out-of-hospital cardiac arrests (OHCAs) correlated with ...
Edwards Lifesciences has announced approval from the US Food and Drug Admini...
The American Heart Association (AHA) has announced that its 2020 Scientific Sess...